美国FDA官员在2011年1月13日举行的一次新闻发布会上宣布,FDA将口服复方镇痛处方药(每片、每粒胶囊或每剂口服液)中乙酰氨基酚的最大剂量限制为325 mg,但此项限制不涉及其任何注射制剂和单方制剂以及OTC产品(如强生公司产品泰诺),目前该类某些处方药的每剂量单位中乙酰氨基酚剂量达750 mg;此举旨在使这类处方药,包 FDA officials announced at a press conference on January 13, 2011 that the agency will limit the maximum dose of acetaminophen in oral compound prescription analgesics (per tablet, capsule or per dose) to 325 mg , But this restriction does not cover any of its injectables and unilateral preparations as well as OTC products (such as Johnson & Johnson’s Tylenol), which currently doses 750 mg of acetaminophen per dosage unit for certain prescription drugs of this type, Such prescription drugs, packages